| Date Filed | Type | Description |
| 03/03/2023 |
4
| Lorianne Masuoka K. (Director) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 2,000 shares
@ $20, valued at
$40k
Granted 5,000 options to buy
@ $10.8, valued at
$54k
|
|
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/23/2019 |
4
| Lorianne Masuoka K. (Chief Medical Officer) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Granted 60,000 options to buy
@ $1.12, valued at
$67.2k
|
|
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2017 |
4
| Lorianne Masuoka K. (Chief Medical Officer) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Granted 150,000 options to buy
@ $6.19, valued at
$928.5k
|
|
| 12/11/2015 |
4
| Lorianne Masuoka K. (Chief Medical Officer) has filed a Form 4 on INVIVO THERAPEUTICS HOLDINGS CORP.|
Txns:
| Granted 115,050 options to buy
@ $7.37, valued at
$847.9k
|
|
| 03/04/2015 |
4
| Lorianne Masuoka K. (Chief Medical Officer) has filed a Form 4 on INVIVO THERAPEUTICS HOLDINGS CORP.|
Txns:
| Granted 500,000 options to buy
@ $3.02, valued at
$1.5M
|
|
| 02/10/2011 |
4
| Lorianne Masuoka K. (Chief Medical Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 75,000 options
@ $10.69, valued at
$801.8k
|
|
| 02/03/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/04/2009 |
3
| Form 3 - Initial statement of beneficial ownership of securities |